{"schema_version":"1","generated_at":"2026-11-04T00:26:12.405Z","data_as_of":null,"url":"https://www.findmykol.com/kol/poorva-vaidya","json_url":"https://www.findmykol.com/kol/poorva-vaidya/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"poorva-vaidya","name":"Poorva Vaidya","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of California, Irvine","institution_url":"https://www.findmykol.com/institution/university-of-california-irvine","city":"Orange","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1407387566","orcid":"0000-0002-5506-4250","openalex":"A5090788292"},"summary":"Poorva Vaidya is an Oncology physician affiliated with University of California, Irvine. OpenAlex indexes 13 publications with 204 citations (h-index 6).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":13,"cited_by_count":204,"h_index":6,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":7,"program_years":{"first":2021,"last":null},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"Immunocore Limited","program_year":2025,"amount_usd":2310.56,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1407387566"},{"payer":"Regeneron Pharmaceuticals, Inc.","program_year":2025,"amount_usd":115.89,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1407387566"},{"payer":"Regeneron Healthcare Solutions, Inc.","program_year":2024,"amount_usd":125.01,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1407387566"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1407387566","source":"payments"},"prescribing":{"data_year":2020,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cardiovascular","share_pct":68.6,"classes_total":2,"classes":[{"class":"Statin","setting":"prescribed","share_pct":45.1,"drugs":[{"name":"Atorvastatin Calcium","share_pct":100}],"max_beneficiaries":13},{"class":"Calcium channel blocker","setting":"prescribed","share_pct":23.5,"drugs":[{"name":"Amlodipine Besylate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":31.4,"classes_total":1,"classes":[{"class":"Biguanide (metformin)","setting":"prescribed","share_pct":31.4,"drugs":[{"name":"Metformin Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":13,"shown":5,"withheld":8,"matched_by":"OpenAlex author record","recent":[{"title":"Induction Systemic Therapy Followed by Response-Adapted Consolidative Radiation in Locally Advanced Non-Melanoma Skin Cancer: A Retrospective Case Series","year":2026,"journal":"Current Oncology","source_url":"https://doi.org/10.3390/curroncol33100602","status":"verified"},{"title":"Phase 2 study of metronomic cyclophosphamide with pembrolizumab in checkpoint inhibitor–refractory melanoma.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.tps9599","status":"verified"},{"title":"Molecular Characterization of Polyomavirus-Positive and Negative Merkel Cell Carcinoma","year":2025,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers17213508","status":"verified"},{"title":"604 Phase 2 study of neoadjuvant nivolumab + relatlimab versus nivolumab in patients with resectable high-risk basal cell carcinoma","year":2025,"journal":"Regular and Young Investigator Award Abstracts","source_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0604","status":"verified"},{"title":"Facts and Hopes in Neoadjuvant Immunotherapy: Current Approvals and Emerging Evidence","year":2023,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-23-0583","status":"verified"}],"source":"works"},"contact":{"address_1":"101 THE CITY DR S","city":"Orange","state":"CA","zip":"928683298","phone":"714-456-8000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1407387566","source":"identity"},"similar":[{"name":"Susan O’Brien","slug":"susan-obrien","institution":"University of California, Irvine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/susan-obrien","json_url":"https://www.findmykol.com/kol/susan-obrien/profile.json"},{"name":"Steven Potkin","slug":"steven-potkin","institution":"University of California, Irvine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/steven-potkin","json_url":"https://www.findmykol.com/kol/steven-potkin/profile.json"},{"name":"Stefan Ciurea","slug":"stefan-ciurea","institution":"University of California, Irvine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stefan-ciurea","json_url":"https://www.findmykol.com/kol/stefan-ciurea/profile.json"},{"name":"Farshid Dayyani","slug":"farshid-dayyani","institution":"University of California, Irvine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/farshid-dayyani","json_url":"https://www.findmykol.com/kol/farshid-dayyani/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":4,"publications":8}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-09-05","provider_certified":"2024-09-05","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2020}},"methodology_url":"https://www.findmykol.com/about#methodology"}